76 related articles for article (PubMed ID: 2418963)
1. A cytogenetic study of familial medullary carcinoma of the thyroid.
Wurster-Hill DH; Noll WW; Bircher LY; Devlin J; Schultz E
Cancer Res; 1986 Apr; 46(4 Pt 2):2134-8. PubMed ID: 2418963
[TBL] [Abstract][Full Text] [Related]
2. [Clinico-genetic aspects of medullary thyroid cancer].
Gar'kavtseva RF; Lisnianskiĭ IE
Vopr Onkol; 1989; 35(6):663-8. PubMed ID: 2568716
[TBL] [Abstract][Full Text] [Related]
3. Quantitative study of a proposed interstitial del (20p 12.2) in multiple endocrine neoplasia (MEN-II).
Krizman DB; Pathak S; Samaan NA; Chong JL; Hickey RC
Anticancer Res; 1986; 6(2):191-4. PubMed ID: 2871802
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous and induced chromosome damage in lymphocytes of medullary thyroid carcinoma patients and their family members.
Tsioupra K; West LF; Davis MB; Parrington JM; Delhanty JD
Dis Markers; 1988 Jun; 6(2):127-32. PubMed ID: 2456871
[TBL] [Abstract][Full Text] [Related]
5. Low incidence of loss of chromosome 10 in sporadic and hereditary human medullary thyroid carcinoma.
Nelkin BD; Nakamura Y; White RW; de Bustros AC; Herman J; Wells SA; Baylin SB
Cancer Res; 1989 Aug; 49(15):4114-9. PubMed ID: 2568166
[TBL] [Abstract][Full Text] [Related]
6. Chromosome 20 deletion in multiple endocrine neoplasia type 2: expanded double-blind studies.
Babu VR; Van Dyke DL; Flejter WL; Jackson CE
Am J Med Genet; 1987 Jul; 27(3):739-48. PubMed ID: 2888311
[TBL] [Abstract][Full Text] [Related]
7. Mapping the inherited defects associated with multiple endocrine neoplasia type 2A, multiple endocrine neoplasia type 2B, and familial medullary thyroid carcinoma to chromosome 10 by linkage analysis.
Goodfellow PJ
Endocrinol Metab Clin North Am; 1994 Mar; 23(1):177-85. PubMed ID: 7913024
[No Abstract] [Full Text] [Related]
8. [Medullary thyroid carcinoma and some of its particularities].
Sidibé el H
Sante; 2007; 17(1):51-5. PubMed ID: 17897902
[TBL] [Abstract][Full Text] [Related]
9. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
Ekblom M; Välimäki M; Pelkonen R; Jansson R; Sivula A; Franssila K
Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic studies on patients with medullary carcinoma of the thyroid.
Le Coniat M; Vecchione D; Pacot A; Bernheim A; Berger R; Gardet P; Parmentier C
Cancer Genet Cytogenet; 1987 Apr; 25(2):303-7. PubMed ID: 2881618
[TBL] [Abstract][Full Text] [Related]
11. [Experience with presymptomatic screening of patients with C cell carcinoma of the thyroid gland].
Frilling A; Röher HD; Ponder BA; Goretzki PE; Schlaghecke R; Reiners C
Chirurg; 1993 Jan; 64(1):28-35. PubMed ID: 8094664
[TBL] [Abstract][Full Text] [Related]
12. Hereditary medullary thyroid carcinoma: genetic annalysis of three related syndromes. Groupe d'Etude des Tumeurs a Calcitonine.
Sobol H; Narod SA; Schuffenecker I; Amos C; Ezekowitz RA; Lenoir GM
Henry Ford Hosp Med J; 1989; 37(3-4):109-11. PubMed ID: 2576938
[TBL] [Abstract][Full Text] [Related]
13. [A familial case of multiple endocrine neoplasia (MEN IIb). Diagnosis of medullary thyroid cancer].
Rochiccioli P; Tauber MT; Pienkowski C
J Genet Hum; 1989 Sep; 37(3):207-14. PubMed ID: 2576280
[TBL] [Abstract][Full Text] [Related]
14. Hereditary medullary thyroid carcinoma.
Vasen HF; Vermey A
Cancer Detect Prev; 1995; 19(2):143-50. PubMed ID: 7750101
[TBL] [Abstract][Full Text] [Related]
15. Family screening in medullary thyroid carcinoma presenting without a family history.
Ponder BA; Finer N; Coffey R; Harmer CL; Maisey M; Ormerod MG; Pembrey ME; Ponder MA; Rosswick P; Shalet S
Q J Med; 1988 Apr; 67(252):299-308. PubMed ID: 2905066
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic approach, genetic screening and prognostic factors of medullary thyroid carcinoma.
Corsello SM; Lovicu RM; Migneco MG; Rufini V; Summaria V
Rays; 2000; 25(2):257-66. PubMed ID: 11370543
[TBL] [Abstract][Full Text] [Related]
17. A rapid screening method for the detection of mutations in the RET proto-oncogene in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma families.
Marsh DJ; Robinson BG; Andrew S; Richardson AL; Pojer R; Schnitzler M; Mulligan LM; Hyland VJ
Genomics; 1994 Sep; 23(2):477-9. PubMed ID: 7835899
[TBL] [Abstract][Full Text] [Related]
18. Bleomycin-induced chromosome damage in lymphocytes of medullary thyroid carcinoma patients and their family members.
Cherry LM; Hsu TC
Anticancer Res; 1983; 3(6):367-72. PubMed ID: 6200055
[TBL] [Abstract][Full Text] [Related]
19. Association of mitochondrial DNA transversion mutations with familial medullary thyroid carcinoma/multiple endocrine neoplasia type 2 syndrome.
Abu-Amero KK; Alzahrani AS; Zou M; Shi Y
Oncogene; 2006 Feb; 25(5):677-84. PubMed ID: 16205644
[TBL] [Abstract][Full Text] [Related]
20. Multiple endocrine neoplasia type IIb: a description of several patients and review of the literature.
Montgomery TB; Mandelstam P; Tachman ML; Miller RE; Powell DE; Flueck JA; Kotchen TA
J Clin Hypertens; 1987 Mar; 3(1):31-49. PubMed ID: 2883264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
